LATEST

Off the Wire

IN FOCUS

Tumor Cell ‘Homing’ and the Mastectomy vs. Lumpectomy Debate

Notable breast surgeon and researcher, Dr. Kefah Mokbel, is advocating the benefits of breast-conserving therapy over mastectomy in certain patients, based on a combination of clinical evidence...

Study Links Air Pollution to More Severe Breast Cancer Cases

A groundbreaking study has revealed a concerning connection between air pollution and the severity of breast cancer, shedding light on how our environment could be affecting our...

New Research Shines Light on Hormone Therapy Resistance in Breast Cancer

Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment. A key breakthrough from...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Breast Cancer Survivors Have Unique Metabolic Needs: Implications for Nutrition

A recent study from the University of Antwerp in Belgium has revealed that breast cancer survivors have higher metabolic rates relative to muscle mass...

Olaparib Study Cites Manageable Side Effects, No Lasting Quality of Life Impact

A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...

Study Finds Depression, Not Sleep, Can Elevate Breast Cancer Risk

Imagine you're trying to predict the weather. You look at factors like cloud cover and temperature, but you're not sure if they're reliable indicators...

What a Massive Study of 12 Million Says About Breast Cancer Screening, Rates

A recent study, remarkable for its sheer sample size, sheds light on the escalating issue of breast cancer among women in China, highlighting a...

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims...

DRUG DEVELOPMENT